TA
VNDA icon

Teachers Advisors’s Vanda Pharmaceuticals VNDA Stock Holding History

Teachers Advisors’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$13.5M Sell
735,161
-11,402
-2% -$260K 0.02% 842
2018
Q4 		$19.5M Buy
746,563
+25,261
+4% +$594K 0.03% 625
2018
Q3 		$16.6M Buy
721,302
+1,201
+0.2% +$24.5K 0.02% 821
2018
Q2 		$13.7M Buy
720,101
+9,173
+1% +$153K 0.02% 933
2018
Q1 		$12M Buy
710,928
+8,900
+1% +$149K 0.02% 953
2017
Q4 		$10.7M Buy
702,028
+5,690
+0.8% +$84.4K 0.01% 1015
2017
Q3 		$12.5M Buy
696,338
+86,000
+14% +$1.44M 0.02% 940
2017
Q2 		$9.95M Buy
610,338
+74,477
+14% +$1.07M 0.01% 1005
2017
Q1 		$7.5M Buy
535,861
+5,180
+1% +$73.8K 0.01% 1106
2016
Q4 		$8.46M Buy
530,681
+39,340
+8% +$632K 0.01% 1032
2016
Q3 		$8.18M Buy
491,341
+36,470
+8% +$491K 0.01% 1019
2016
Q2 		$5.09M Buy
454,871
+395,224
+663% +$3.83M 0.01% 1166
2016
Q1 		$499K Hold
59,647
– – ﹤0.01% 2342
2015
Q4 		$555K Hold
59,647
– – ﹤0.01% 2345
2015
Q3 		$673K Hold
59,647
– – ﹤0.01% 2213
2015
Q2 		$757K Buy
59,647
+6,754
+13% +$72.8K ﹤0.01% 2282
2015
Q1 		$492K Buy
52,893
+5,139
+11% +$58.1K ﹤0.01% 2439
2014
Q4 		$684K Sell
47,754
-10,000
-17% -$118K ﹤0.01% 2252
2014
Q3 		$599K Hold
57,754
– – ﹤0.01% 2299
2014
Q2 		$934K Buy
57,754
+7,252
+14% +$96.6K ﹤0.01% 2071
2014
Q1 		$821K Buy
50,502
+4,080
+9% +$58K ﹤0.01% 2142
2013
Q4 		$576K Buy
46,422
+3,710
+9% +$37.3K ﹤0.01% 2308
2013
Q3 		$469K Buy
42,712
+7,331
+21% +$78.3K ﹤0.01% 2353
2013
Q2 		$286K Buy
+35,381
New +$238K ﹤0.01% 2566

Other funds holding VNDA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Teachers Advisors's VNDA Position: Q1 2019 in Review

Teachers Advisors reduced its Vanda Pharmaceuticals (VNDA) stake by 1.5% in Q1 2019, selling an estimated $260K and leaving 735,161 shares worth $13.5M. The position accounts for 0.02% of the portfolio, ranked #842.

Teachers Advisors first reported a position in VNDA in Q2 2013 and has held it in 24 quarters since. The position peaked at $19.5M in Q4 2018. 179 funds tracked by Wall St. Rank hold VNDA as of Q1 2019.

  • Teachers Advisors held 735,161 shares of Vanda Pharmaceuticals worth $13.5M as of Q1 2019.
  • Teachers Advisors sold 11,402 Vanda Pharmaceuticals shares in Q1 2019, an estimated $260K.
  • Vanda Pharmaceuticals made up 0.02% of Teachers Advisors's portfolio in Q1 2019, its #842 holding.
  • Teachers Advisors first reported a position in Vanda Pharmaceuticals in Q2 2013 and has held it in 24 quarters since.
  • Teachers Advisors's Vanda Pharmaceuticals position peaked at $19.5M in Q4 2018.
  • 179 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q1 2019.

Based on Teachers Advisors's 13F filing for Q1 2019, filed 14 May 2019.